JOINT PAIN INJECTIONS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America remains the dominant region in the global joint pain injections market and is estimated to hold 34.9% of the market share in 2024 due to early adoption of advanced technologies and growing prevalence of arthritis. As per the estimates by Arthritis Foundation, by the year 2040, it is estimated that the number of adults in the U.S. diagnosed with arthritis by a doctor will rise by 49%, reaching a total of 78.4 million individuals, which would represent 25.9% of all adults. Additionally, the number of adults facing limitations in daily activities attributable to arthritis is projected to increase by 52%, reaching 34.6 million individuals, or 11.4% of all adults.

The Asia Pacific region is emerging as the fastest growing market for joint pain injections. China and India as the most populated countries are witnessing tremendous increase in geriatric population susceptible to osteoarthritis and other forms of arthritis. This has ramped up the requirement for pain relief measures. Additionally, improving access to healthcare coupled with growing medical tourism industry are attracting patients from other regions to the Asia Pacific. Rising disposable income allows individuals to spend on expensive treatments, fueling the joint injections sales.